ALDX logo

Aldeyra Therapeutics (ALDX) Operating Profit

Annual Operating Profit

-$60.12 M
-$17.32 M-40.48%

December 1, 2024


Summary


Performance

ALDX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALDXprofitabilitymetrics:

Quarterly Operating Profit

-$16.58 M
-$440.20 K-2.73%

December 1, 2024


Summary


Performance

ALDX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALDXprofitabilitymetrics:

TTM Operating Profit

-$60.12 M
-$10.48 M-21.11%

December 1, 2024


Summary


Performance

ALDX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALDXprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

ALDX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-40.5%0.0%0.0%
3 y3 years-6.9%-7.6%-6.9%
5 y5 years-6.4%-29.2%-6.4%

ALDX Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-40.5%+4.1%-171.9%+7.9%-69.9%+7.6%
5 y5-year-73.4%+4.1%-171.9%+7.9%-73.4%+7.6%
alltimeall time-5295.5%+4.1%<-9999.0%+13.0%<-9999.0%+7.6%

Aldeyra Therapeutics Operating Profit History

DateAnnualQuarterlyTTM
Dec 2024
-$60.12 M(+40.5%)
-$16.58 M(+2.7%)
-$60.12 M(+21.1%)
Sep 2024
-
-$16.14 M(-10.4%)
-$49.64 M(+15.3%)
Jun 2024
-
-$18.01 M(+91.7%)
-$43.05 M(+21.7%)
Mar 2024
-
-$9.39 M(+54.1%)
-$35.38 M(-17.3%)
Dec 2023
-$42.79 M(-31.7%)
-$6.10 M(-36.2%)
-$42.79 M(-15.1%)
Sep 2023
-
-$9.55 M(-7.7%)
-$50.39 M(-9.4%)
Jun 2023
-
-$10.34 M(-38.4%)
-$55.63 M(-11.7%)
Mar 2023
-
-$16.80 M(+22.7%)
-$63.00 M(+0.5%)
Dec 2022
-$62.68 M(+11.5%)
-$13.70 M(-7.4%)
-$62.68 M(-2.7%)
Sep 2022
-
-$14.78 M(-16.5%)
-$64.39 M(-1.0%)
Jun 2022
-
-$17.71 M(+7.5%)
-$65.04 M(+5.1%)
Mar 2022
-
-$16.48 M(+7.0%)
-$61.87 M(+10.1%)
Dec 2021
-$56.22 M(+62.2%)
-$15.40 M(-0.2%)
-$56.22 M(+11.7%)
Sep 2021
-
-$15.44 M(+6.2%)
-$50.35 M(+16.3%)
Jun 2021
-
-$14.54 M(+34.3%)
-$43.30 M(+20.7%)
Mar 2021
-
-$10.83 M(+13.6%)
-$35.86 M(+3.4%)
Dec 2020
-$34.67 M(-38.6%)
-$9.53 M(+13.6%)
-$34.67 M(-8.7%)
Sep 2020
-
-$8.39 M(+18.1%)
-$37.96 M(-21.9%)
Jun 2020
-
-$7.11 M(-26.3%)
-$48.64 M(-12.1%)
Mar 2020
-
-$9.64 M(-24.9%)
-$55.31 M(-2.1%)
Dec 2019
-$56.51 M(+42.3%)
-$12.83 M(-32.7%)
-$56.51 M(+3.2%)
Sep 2019
-
-$19.06 M(+38.3%)
-$54.77 M(+17.4%)
Jun 2019
-
-$13.78 M(+27.2%)
-$46.66 M(+11.0%)
Mar 2019
-
-$10.83 M(-2.4%)
-$42.04 M(+5.9%)
Dec 2018
-$39.70 M
-$11.10 M(+1.4%)
-$39.70 M(+11.4%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$10.95 M(+19.4%)
-$35.65 M(+20.0%)
Jun 2018
-
-$9.17 M(+7.9%)
-$29.72 M(+14.8%)
Mar 2018
-
-$8.49 M(+20.5%)
-$25.88 M(+15.1%)
Dec 2017
-$22.49 M(+20.3%)
-$7.05 M(+40.5%)
-$22.49 M(+11.9%)
Sep 2017
-
-$5.02 M(-5.9%)
-$20.09 M(+1.2%)
Jun 2017
-
-$5.33 M(+4.6%)
-$19.86 M(+5.5%)
Mar 2017
-
-$5.10 M(+9.5%)
-$18.82 M(+0.7%)
Dec 2016
-$18.70 M(+55.9%)
-$4.65 M(-2.6%)
-$18.69 M(+1.7%)
Sep 2016
-
-$4.78 M(+11.2%)
-$18.38 M(+8.5%)
Jun 2016
-
-$4.30 M(-13.5%)
-$16.94 M(+14.1%)
Mar 2016
-
-$4.97 M(+14.5%)
-$14.85 M(+23.8%)
Dec 2015
-$11.99 M(+64.9%)
-$4.34 M(+30.0%)
-$11.99 M(+19.2%)
Sep 2015
-
-$3.34 M(+51.4%)
-$10.06 M(+15.8%)
Jun 2015
-
-$2.20 M(+4.5%)
-$8.69 M(+6.9%)
Mar 2015
-
-$2.11 M(-12.5%)
-$8.13 M(+11.9%)
Dec 2014
-$7.27 M(+97.8%)
-$2.41 M(+22.5%)
-$7.27 M(+19.3%)
Sep 2014
-
-$1.97 M(+19.5%)
-$6.09 M(+15.2%)
Jun 2014
-
-$1.65 M(+32.3%)
-$5.29 M(+14.3%)
Mar 2014
-
-$1.24 M(+1.0%)
-$4.63 M(+25.9%)
Dec 2013
-$3.68 M(+230.0%)
-$1.23 M(+5.7%)
-$3.68 M(+43.6%)
Sep 2013
-
-$1.17 M(+18.3%)
-$2.56 M(+83.7%)
Jun 2013
-
-$985.70 K(+238.1%)
-$1.39 M(+241.7%)
Mar 2013
-
-$291.50 K(+150.4%)
-$407.90 K(+250.4%)
Dec 2012
-$1.11 M(-47.2%)
-$116.40 K
-$116.40 K
Dec 2011
-$2.11 M
-
-

FAQ

  • What is Aldeyra Therapeutics annual operating income?
  • What is the all time high annual operating profit for Aldeyra Therapeutics?
  • What is Aldeyra Therapeutics annual operating profit year-on-year change?
  • What is Aldeyra Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Aldeyra Therapeutics?
  • What is Aldeyra Therapeutics quarterly operating profit year-on-year change?
  • What is Aldeyra Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Aldeyra Therapeutics?
  • What is Aldeyra Therapeutics TTM operating profit year-on-year change?

What is Aldeyra Therapeutics annual operating income?

The current annual operating profit of ALDX is -$60.12 M

What is the all time high annual operating profit for Aldeyra Therapeutics?

Aldeyra Therapeutics all-time high annual operating income is -$1.11 M

What is Aldeyra Therapeutics annual operating profit year-on-year change?

Over the past year, ALDX annual operating income has changed by -$17.32 M (-40.48%)

What is Aldeyra Therapeutics quarterly operating income?

The current quarterly operating profit of ALDX is -$16.58 M

What is the all time high quarterly operating profit for Aldeyra Therapeutics?

Aldeyra Therapeutics all-time high quarterly operating income is -$116.40 K

What is Aldeyra Therapeutics quarterly operating profit year-on-year change?

Over the past year, ALDX quarterly operating income has changed by $0.00 (0.00%)

What is Aldeyra Therapeutics TTM operating income?

The current TTM operating profit of ALDX is -$60.12 M

What is the all time high TTM operating profit for Aldeyra Therapeutics?

Aldeyra Therapeutics all-time high TTM operating income is -$116.40 K

What is Aldeyra Therapeutics TTM operating profit year-on-year change?

Over the past year, ALDX TTM operating income has changed by $0.00 (0.00%)